Withdraw. Comparison of remimazolam and propofol in postoperative delirium in elderly patients undergoing radical resection of colon cancer

Comparison of remimazolam and propofol in postoperative delirium in elderly patients undergoing radical resection of colon cancer

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200060498

Enrollment

Unknown

Registered

2022-06-03

Start date

2022-05-24

Completion date

Unknown

Last updated

2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

delirium

Interventions

Group R:Remimazolam

Group P:Propofol

Eligibility

Sex/Gender

All

Age

65 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Elderly patients aged >=65 years; 2. Patients undergoing radical resection of colon cancer; 3. Preoperative MMSE>=24; 4. ASA grade I to III.

Exclusion criteria

Exclusion criteria: 1. Allergic to study drugs; 2. Severe heart and lung disease, liver or kidney failure; 3. Patients with a history of mental illness or a history of central nervous system disease.

Design outcomes

Primary

Measure	Time frame
Postoperative delirium;	—

Countries

China

Contacts

Public ContactLiu Tianlin

Cangzhou Central Hospital

1377689587@qq.com+86 180 0337 0383

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026